Conventional allogeneic transplantation (allo-BMT) saves lives, but carries high complications, burden on quality of life and limitations on survival. Next-generation life-saving therapies

G-Treg: First product G-Treg transforms transplantation by being a graft enriched with regulatory T cells designed to modulate the immune response from

Platform strategy Development of a GMP center with export capacity to become the regional hub for technology transfer. Anchor of innovation at

Impact World-class regional infrastructure that saves lives Better transplant outcomes Reduction of severe complications Greater regional access to advanced therapies Strengthening regional